Early blood rise in auto‑antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic‑non‑small cell lung cancer patients treated with PD‑1 immune‑check point blockade by nivolumab

  • Rocco Giannicola
    Medical Oncology Unit, ‘Bianchi‑Melacrino‑Morelli’ Grand Metropolitan Hospital, I‑89124 Reggio di Calabria, Italy
  • Graziella D'Arrigo
    Statistical Unit, National Council of Research (CNR), Grand Metropolitan Hospital‑IFC, I‑89124 Reggio di Calabria, Italy
  • Cirino Botta
    Medical Oncology Unit, Department of Experimental and Clinical Medicine, Magna Graecia University, I‑88100 Catanzaro, Italy
  • Rita Agostino
    Medical Oncology Unit, ‘Bianchi‑Melacrino‑Morelli’ Grand Metropolitan Hospital, I‑89124 Reggio di Calabria, Italy
  • Pietro Del Medico
    Medical Oncology Unit, ‘Bianchi‑Melacrino‑Morelli’ Grand Metropolitan Hospital, I‑89124 Reggio di Calabria, Italy
  • Antonia Falzea
    Medical Oncology Unit, ‘Bianchi‑Melacrino‑Morelli’ Grand Metropolitan Hospital, I‑89124 Reggio di Calabria, Italy
  • Vito Barbieri
    Medical Oncology Unit, Department of Experimental and Clinical Medicine, Magna Graecia University, I‑88100 Catanzaro, Italy
  • Nicoletta Staropoli
    Medical Oncology Unit, Department of Experimental and Clinical Medicine, Magna Graecia University, I‑88100 Catanzaro, Italy
  • Teresa Del Giudice
    Medical Oncology Unit, Department of Experimental and Clinical Medicine, Magna Graecia University, I‑88100 Catanzaro, Italy
  • Pierpaolo Pastina
    Radiation Oncology Unit, Siena University Hospital, I‑53100 Siena, Italy
  • Valerio Nardone
    Radiation Oncology Unit, Siena University Hospital, I‑53100 Siena, Italy
  • Marika Monoriti
    Autoimmunity Laboratory, ‘Bianchi‑Melacrino‑Morelli’ Grand Metropolitan Hospital, I‑89124 Reggio di Calabria, Italy
  • Graziella Calabrese
    Radiology Unit, ‘Bianchi‑Melacrino‑Morelli’ Grand Metropolitan Hospital, I‑89124 Reggio di Calabria, Italy
  • Giovanni Tripepi
    Statistical Unit, National Council of Research (CNR), Grand Metropolitan Hospital‑IFC, I‑89124 Reggio di Calabria, Italy
  • Luigi Pirtoli
    Radiation Oncology Unit, Siena University Hospital, I‑53100 Siena, Italy
  • Pierfrancesco Tassone
    Medical Oncology Unit, Department of Experimental and Clinical Medicine, Magna Graecia University, I‑88100 Catanzaro, Italy
  • Pierosandro Tagliaferri
    Medical Oncology Unit, Department of Experimental and Clinical Medicine, Magna Graecia University, I‑88100 Catanzaro, Italy
  • Pierpaolo Correale
    Medical Oncology Unit, ‘Bianchi‑Melacrino‑Morelli’ Grand Metropolitan Hospital, I‑89124 Reggio di Calabria, Italy

収録刊行物

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

  • CRID
    1360855568431610624
  • DOI
    10.3892/mco.2019.1859
  • ISSN
    20499469
    20499450
  • データソース種別
    • Crossref

問題の指摘

ページトップへ